Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
1.
Epidemics ; 21: 80-87, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-28916210

RESUMO

OBJECTIVE: Previous HPV models have only included genital transmission, when evidence suggests that transmission between several anatomical sites occurs. We compared model predictions of population-level HPV vaccination effectiveness against genital HPV16 infection in women, using a 1) uni-site (genital site), and a 2) multi-site model (genital and one extragenital site). METHODS: We developed a uni-site and a multi-site deterministic HPV transmission model, assuming natural immunity was either site-specific or systemic. Both models were calibrated to genital HPV16 prevalence (5%-7.5%), whilst the multi-site model was calibrated to HPV16 prevalence representative of oral (0%-1%) and anal (1%-7.5%) sites. For each model, we identified 2500 parameter sets that fit endemic genital and extragenital prevalences within pre-specified target ranges. In the Base-case analysis, vaccination was girls-only with 40% coverage. Vaccine efficacy was 100% for all sites with lifetime protection. The outcome was the relative reduction in genital HPV16 prevalence among women at post-vaccination equilibrium (RRprev). RRprev was stratified by extragenital prevalence pre-vaccination. RESULTS: Under assumptions of site-specific immunity, RRprev with the multi-site model was generally greater than with the uni-site model. Differences between the uni-site and multi-site models were greater when transmission from the extragenital site to the genital site was high. Under assumptions of systemic immunity, the multi-site and uni-site models yielded similar RRprev in the scenario without immunity after extragenital infection. In the scenario with systemic immunity after extragenital infection, the multi-site model yielded lower predictions of RRprev than the uni-site model. CONCLUSIONS: Modelling genital-site only transmission may overestimate vaccination impact if extragenital infections contribute to systemic natural immunity or underestimate vaccination impact if a high proportion of genital infections originate from extragenital infections. Under current understanding of heterosexual HPV transmission and immunity, a substantial bias from using uni-site models in predicting vaccination effectiveness against genital HPV infection is unlikely to occur.


Assuntos
Papillomavirus Humano 16 , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus , Adulto , Análise Custo-Benefício , Feminino , Humanos , Modelos Teóricos , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/transmissão , Prevalência , Vacinação , Adulto Jovem
2.
Clin Transl Sci ; 10(2): 102-109, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28075528

RESUMO

Genetic variation in the platelet endothelial aggregation receptor 1 (PEAR1) gene, most notably rs12041331, is implicated in altered on-aspirin platelet aggregation and increased cardiovascular event risk. We prospectively tested the effects of aspirin administration at commonly prescribed doses (81, 162, and 324 mg/day) on agonist-induced platelet aggregation by rs12041331 genotype in 67 healthy individuals. Prior to aspirin administration, rs12041331 minor allele carriers had significantly reduced adenosine diphosphate (ADP)-induced platelet aggregation compared with noncarriers (P = 0.03) but was not associated with other platelet pathways. In contrast, rs12041331 was significantly associated with on-aspirin platelet aggregation when collagen and epinephrine were used to stimulate platelet aggregation (P < 0.05 for all associations), but not ADP. The influence of PEAR1 rs12041331 on platelet aggregation is pathway-specific and is altered by aspirin at therapeutic doses, but not in a dose-dependent manner. Additional studies are needed to determine the impact of PEAR1 on cardiovascular events in aspirin-treated patients.


Assuntos
Aspirina/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Polimorfismo de Nucleotídeo Único , Receptores de Superfície Celular/genética , Difosfato de Adenosina/farmacologia , Adulto , Alelos , Amish/genética , Biomarcadores/urina , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Colágeno/farmacologia , Epinefrina/farmacologia , Feminino , Genótipo , Voluntários Saudáveis , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Tromboxano B2/urina
3.
Eur J Clin Microbiol Infect Dis ; 35(4): 597-609, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26851949

RESUMO

The purpose of this investigation was to assess the real-life effectiveness of pegylated interferon (peg-IFN) α-2b with ribavirin (RBV) in a cohort of treatment-naïve patients with chronic genotypes 2 (G2) or 3 (G3) hepatitis C virus (HCV) infection. A post-hoc pooled analysis of two Canadian multicenter, observational studies, RediPEN and PoWer, was carried out. A total of 1242 G2- or G3-infected patients were included. The primary outcome was sustained virologic response (SVR). Secondary endpoints included early virologic response (EVR), end-of-treatment (EOT) response, and relapse. Multivariate logistic regression was used to identify independent predictors of treatment response. SVR in G2 and G3 was 74.4 % and 63.6 %, respectively. Relapse occurred in 12.7 % and 19.1 % of G2- and G3-infected patients achieving EOT response, respectively. Overall, G3 was found to independently predict reduced SVR [odds ratio (OR) = 0.20; p = 0.007] and increased relapse (OR = 6.84; p = 0.022). Among G3-infected patients, increasing fibrosis score was the most important factor predicting reduced SVR [F2 vs. F0/F1 (OR = 0.41; p = 0.009); F3 vs. F0/F1 (OR = 0.72; p = 0.338); F4 vs. F0/F1 (OR = 0.27; p = 0.001)]. Male gender (OR = 13.16; p = 0.020) and higher fibrosis score [F2 vs. F0/F1 (OR = 9.72; p = 0.016); F3/F4 vs. F0/F1 (OR = 4.23; p = 0.113)] were associated with increased relapse in G3 patients. These results support the real-life effectiveness of peg-IFN α-2b plus ribavirin in HCV G2- and G3-infected patients. Overall, genotype was identified as the most significant predictor of treatment outcome. Fibrosis score and gender were key outcome predictors in the G3-infected population. In clinical settings, peg-INF/RBV offers an alternative for patients without access to all oral direct-acting antivirals.


Assuntos
Antivirais/uso terapêutico , Genótipo , Hepacivirus/classificação , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/uso terapêutico , Polietilenoglicóis/uso terapêutico , Ribavirina/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Canadá , Feminino , Hepacivirus/genética , Hepatite C Crônica/virologia , Humanos , Interferon alfa-2 , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Proteínas Recombinantes/uso terapêutico , Recidiva , Resultado do Tratamento , Adulto Jovem
4.
Epidemiol Infect ; 144(7): 1490-9, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26584685

RESUMO

For studies examining risk factors of sexually transmitted infections (STIs), confounding can stem from characteristics of partners of study subjects, and persist after adjustment for the subjects' individual-level characteristics. Two conditions that can result in confounding by the subjects' partners are: (C1) partner choice is assortative by the risk factor examined and, (C2) sexual activity is associated with the risk factor. The objective of this paper is to illustrate the potential impact of the assortativity bias in studies examining STI risk factors, using smoking and human papillomavirus (HPV) as an example. We developed an HPV transmission-dynamic mathematical model in which we nested a cross-sectional study assessing the smoking-HPV association. In our base case, we assumed (1) no effect of smoking on HPV, and (2) conditions C1-C2 hold for smoking (based on empirical data). The assortativity bias caused an overestimation of the odds ratio (OR) in the simulated study after perfect adjustment for the subjects' individual-level characteristics (adjusted OR 1·51 instead of 1·00). The bias was amplified by a lower basic reproductive number (R 0), greater mixing assortativity and stronger association of smoking with sexual activity. Adjustment for characteristics of partners is needed to mitigate assortativity bias.


Assuntos
Papillomaviridae/fisiologia , Infecções por Papillomavirus/epidemiologia , Comportamento Sexual , Parceiros Sexuais , Infecções Sexualmente Transmissíveis/epidemiologia , Fumar/epidemiologia , Viés , Estudos Transversais , Humanos , Modelos Teóricos , Razão de Chances , Infecções por Papillomavirus/virologia , Fatores de Risco , Infecções Sexualmente Transmissíveis/etiologia
5.
Pathol Biol (Paris) ; 62(5): 241-51, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25179115

RESUMO

Sleep misperception is often observed in insomnia individuals (INS). The extent of misperception varies between different types of INS. The following paper comprised sections which will be aimed at studying the sleep EEG and compares it to subjective reports of sleep in individuals suffering from either psychophysiological insomnia or paradoxical insomnia and good sleeper controls. The EEG can be studied without any intervention (thus using the raw data) via either PSG or fine quantitative EEG analyses (power spectral analysis [PSA]), identifying EEG patterns as in the case of cyclic alternating patterns (CAPs) or by decorticating the EEG while scoring the different transient or phasic events (K-Complexes or sleep spindles). One can also act on the on-going EEG by delivering stimuli so to study their impact on cortical measures as in the case of event-related potential studies (ERPs). From the paucity of studies available using these different techniques, a general conclusion can be reached: sleep misperception is not an easy phenomenon to quantify and its clinical value is not well recognized. Still, while none of the techniques or EEG measures defined in the paper is available and/or recommended to diagnose insomnia, ERPs might be the most indicated technique to study hyperarousal and sleep quality in different types of INS. More research shall also be dedicated to EEG patterns and transient phasic events as these EEG scoring techniques can offer a unique insight of sleep misperception.


Assuntos
Percepção/fisiologia , Distúrbios do Início e da Manutenção do Sono/psicologia , Sono , Ondas Encefálicas/fisiologia , Diagnóstico Diferencial , Eletroencefalografia/métodos , Eletroencefalografia/estatística & dados numéricos , Potenciais Evocados , Análise de Fourier , Humanos , Prontuários Médicos , Polissonografia , Transtornos Psicofisiológicos/diagnóstico , Transtornos Psicofisiológicos/fisiopatologia , Transtornos Psicofisiológicos/psicologia , Distúrbios do Início e da Manutenção do Sono/classificação , Distúrbios do Início e da Manutenção do Sono/diagnóstico , Distúrbios do Início e da Manutenção do Sono/fisiopatologia , Fases do Sono/fisiologia , Vigília/fisiologia
6.
Parasitology ; 126(Pt 1): 21-30, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12613760

RESUMO

This study reports that inhibition of Leishmania Topo-I with the minor groove-binding ligands (MGBLs) Hoechst 33342 (Ho342) blocks parasite growth in culture by mechanisms involving DNA breakage. While Ho342 inhibited the replication of several species of Leishmania in a dose- and time-dependent manner, Ho258 was not effective. Cytofluorometric analysis suggested that superior effectiveness of Ho342 over Ho258 was attributed to Leishmania parasites being more permeable toward Ho342. This observation was supported by the ability of both Ho342 and Ho258 to block the relaxation of supercoiled pBR322 DNA by Leishmania Topo-I. The Ho342 specificity toward L. donovani Topo-I was reinforced by the observation that increased Topo-I gene expression and Topo-I activity in Leishmania was paralleled by augmented resistance for this compound. Furthermore, the capacity of NaCl treatment to reverse MGBL-mediated DNA break suggests that Ho342 targetted Topo-I. Moreover, we observed that Ho342-inducible arrest of Leishmania growth was accompanied by G1 arrest and induction of cell death that closely resembles apoptosis. Taken together, our results suggest that MGBL compounds show promise as Topo-I inhibitors against Leishmania infection.


Assuntos
Benzimidazóis/farmacologia , Leishmania/efeitos dos fármacos , Leishmania/crescimento & desenvolvimento , Inibidores da Topoisomerase I , Animais , Núcleo Celular/química , Núcleo Celular/efeitos dos fármacos , DNA Topoisomerases Tipo I/genética , DNA Topoisomerases Tipo I/metabolismo , DNA de Protozoário/análise , DNA de Protozoário/química , DNA de Protozoário/genética , Relação Dose-Resposta a Droga , Resistência a Medicamentos/genética , Fase G1/efeitos dos fármacos , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Leishmania/citologia , Leishmania/enzimologia , Fatores de Tempo
7.
Adv Drug Deliv Rev ; 49(3): 223-35, 2001 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-11551396

RESUMO

Originally described in the 1950s caveolae are morphologically identifiable as small omega-shaped plasma membrane invaginations present in most cell types. Caveolae are particularly abundant in adipocytes, fibroblasts, type 1 pneumocytes, endothelial and epithelial cells as well as in smooth and striated muscle cells. The first proposed function for caveolae was that of mediating the internalisation and transendothelial trafficking of solutes. Caveolae have been the object of intense research since the discovery of a biochemical marker protein, caveolin, in the early 1990s. Three genes encoding for caveolins have been characterised in mammals. Caveolins (18-24 kDa) are integral membrane proteins that constitute the major protein component of caveolar membrane in vivo. In addition to a structural role of caveolins in the formation of caveolae, caveolin protein interacts directly, and in a regulated manner, with a number of signalling molecules. We present here a general overview of the current knowledge on the structural role of caveolin in caveolae formation, and implication of caveolin in the control of cell signalling.


Assuntos
Cavéolas/fisiologia , Caveolinas/fisiologia , Animais , Membrana Celular/fisiologia , Humanos , Transdução de Sinais/fisiologia
8.
J Clin Microbiol ; 39(7): 2584-9, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11427573

RESUMO

Bovine mastitis is the most important source of loss for the dairy industry. A rapid and specific test for the detection of the main pathogens of bovine mastitis is not actually available. Molecular probes reacting in PCR with bacterial DNA from bovine milk, providing direct and rapid detection of Escherichia coli, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus parauberis, and Streptococcus uberis, have been developed. Two sets of specific primers were designed for each of these microorganisms and appeared to discriminate close phylogenic bacterial species (e.g., S. agalactiae and S. dysgalactiae). In addition, two sets of universal primers were designed to react as positive controls with all major pathogens of bovine mastitis. The sensitivities of the test using S. aureus DNA extracted from milk with and without a pre-PCR enzymatic lysis step of bacterial cells were compared. The detection limit of the assay was 3.125 x 10(2) CFU/ml of milk when S. aureus DNA was extracted with the pre-PCR enzymatic step compared to 5 x 10(3) CFU/ml of milk in the absence of the pre-PCR enzymatic step. This latter threshold of sensitivity is still compatible with its use as an efficient tool of diagnosis in bovine mastitis, allowing the elimination of expensive reagents. The two PCR tests avoid cumbersome and lengthy cultivation steps, can be performed within hours, and are sensitive, specific, and reliable for the direct detection in milk of the six most prevalent bacteria causing bovine mastitis.


Assuntos
Escherichia coli/isolamento & purificação , Mastite Bovina/microbiologia , Reação em Cadeia da Polimerase/métodos , Staphylococcus aureus/isolamento & purificação , Streptococcus/isolamento & purificação , Animais , Bovinos , Primers do DNA , DNA Bacteriano/análise , Escherichia coli/classificação , Feminino , Sensibilidade e Especificidade , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/veterinária , Staphylococcus aureus/classificação , Infecções Estreptocócicas/microbiologia , Infecções Estreptocócicas/veterinária , Streptococcus/classificação , Fatores de Tempo
9.
Cloning Stem Cells ; 3(3): 151-5, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11945224

RESUMO

Three, genetically identical, Nigerian Dwarf bucks produced by somatic cell nuclear transfer (NT) of fetal fibroblasts were monitored for sexual maturation and fertility. Starting at four months of age, these male clones were trained to serve an artificial vagina (AV). Average age of the NT-derived bucks at first semen collection was 20 weeks, which was not different from that of other young bucks of this breed (average age at first collection = 20 weeks). Average sperm production at 5 months of age for the NT-derived bucks was 5.0 x 10(8) spermatozoa, which was comparable to that of dwarf bucks of similar age (3.4 x 10(8) spermatozoa). At seven months of age, semen collected from two NT-derived bucks was used to artificially inseminate six females (three does per buck). Five does were confirmed pregnant by ultrasound at day 42. Nine healthy kids, four males and five females, were born in March and April 2000. Viable spermatozoa were collected from one of the F1 males at 28 weeks of age. These results demonstrated that NT-derived bucks and one of their male offspring developed sexually within the normal timeframe for their breed and that the clones were fertile.


Assuntos
Clonagem de Organismos/veterinária , Fertilidade , Cabras/genética , Técnicas de Transferência Nuclear , Maturidade Sexual , Animais , Animais Geneticamente Modificados/embriologia , Animais Geneticamente Modificados/crescimento & desenvolvimento , Cruzamento , Fusão Celular , Sobrevivência Celular , Desenvolvimento Embrionário e Fetal/fisiologia , Feminino , Fibroblastos/fisiologia , Cabras/embriologia , Cabras/crescimento & desenvolvimento , Inseminação Artificial/veterinária , Masculino , Gravidez , Sêmen/fisiologia , Espermatozoides/citologia , Espermatozoides/fisiologia , Fatores de Tempo
10.
Am J Phys Med Rehabil ; 79(6): 526-35, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11083303

RESUMO

OBJECTIVE: To determine the prevalence of secondary impairments among individuals with long-standing spinal cord injury in Quebec and the potential relationships between these impairments and several variables. DESIGN: A review of 2,200 medical files was conducted to determine the target population; 976 patients were selected randomly and mailed questionnaires. The results were based on 482 individuals with spinal cord injury who returned the completed questionnaire. The questionnaire included 14 subsections, such as sociodemographic, medical, psychosocial, and environmental information. The medical section, including the type and level of lesion and the presence of secondary impairments, was analyzed. RESULTS: Urinary tract infection, spasticity, and hypotension were the most frequently reported secondary impairments, regardless of the severity of injury. Relationships between the prevalence of secondary impairments and the duration of injury, as well as perceived health status, were observed. CONCLUSIONS: This is the first study to describe secondary impairments after long-standing spinal cord injury in Quebec. Patients with spinal cord injury still present a high prevalence of secondary impairments many years after their rehabilitation, despite preventive education or medical follow-up visits. Further studies are required to determine the specific impact that these impairments have on the patients' social role and their quality-of-life.


Assuntos
Nível de Saúde , Traumatismos da Medula Espinal/complicações , Adulto , Idoso , Disreflexia Autonômica/epidemiologia , Disreflexia Autonômica/etiologia , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Hipotensão/epidemiologia , Hipotensão/etiologia , Renda , Masculino , Pessoa de Meia-Idade , Espasticidade Muscular/epidemiologia , Espasticidade Muscular/etiologia , Úlcera por Pressão/epidemiologia , Úlcera por Pressão/etiologia , Prevalência , Quebeque/epidemiologia , Dor de Ombro/epidemiologia , Dor de Ombro/etiologia , Traumatismos da Medula Espinal/economia , Traumatismos da Medula Espinal/epidemiologia , Fatores de Tempo , Infecções Urinárias/epidemiologia , Infecções Urinárias/etiologia
11.
Res Microbiol ; 151(7): 563-74, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11037134

RESUMO

Escherichia coli O115:F165 strains are associated with septicaemia in young pigs and possess at least two types of fimbriae. F165(1) fimbriae belong to the P fimbrial family and F165(2) fimbriae belong to the S fimbrial family. Regulatory regions of foo (F165(1)) and fot (F165(2)) fimbrial gene clusters from wild-type strain 4787 were sequenced and characterised. Expression of F165(1) and F165(2) fimbrial genes was analysed by using lacZ and/or luxAB as reporter genes under the control of the native fimbrial promoters. Differential expression of fimbrial genes was observed. Global regulatory mechanisms such as catabolite repression, leucine-responsive regulatory protein (Lrp), methylation and DNA supercoiling were demonstrated to influence foo and fot expression. foo and fot expression was optimal at 37 degrees C and under aerobic conditions. Expression of foo was higher on minimal medium, whereas fot expression was higher on complex Luria-Bertani medium. This could reflect an in vivo differential expression.


Assuntos
Antígenos de Bactérias , Proteínas de Bactérias/genética , Proteínas de Escherichia coli , Escherichia coli/genética , Proteínas de Fímbrias , Fímbrias Bacterianas/genética , Regulação Bacteriana da Expressão Gênica , Genes Reguladores , Sequência de Aminoácidos , Animais , Bacteriemia/microbiologia , Bacteriemia/veterinária , Proteínas de Bactérias/metabolismo , Sequência de Bases , DNA Super-Helicoidal , Escherichia coli/patogenicidade , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/veterinária , Genes Reporter , Dados de Sequência Molecular , Óperon , Regiões Promotoras Genéticas , Suínos , Doenças dos Suínos/microbiologia , Virulência
12.
Mol Microbiol ; 35(1): 58-68, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10632877

RESUMO

One major function of DNA topoisomerase I in Escherichia coli is to repress R-loop formation during transcription elongation, which may otherwise inhibit cell growth. We have previously shown that the growth problems of topA mutants can be corrected by overproducing RNase H, an enzyme that degrades the RNA moiety of an R-loop. The goal of the present study was to identify other potential regulators of R-loop formation. To this end, we have screened for multicopy suppressors of topA null mutations. As expected using this procedure, we cloned the rnhA gene encoding RNase H. In addition, we also identified the topB gene encoding DNA topoisomerase III as an efficient suppressor of topA null mutations and, hence, of R-loop formation. We show that DNA topoisomerase III is able to relax transcription-induced negative supercoiling both in vitro and in vivo. An R-loop is also shown to be a hot-spot for relaxation by DNA topoisomerase III, and we found that R-loop-dependent hypernegative supercoiling can be prevented by the activity of this topoisomerase in vivo. It is also shown that the topB gene can act synergistically with the rnhA gene to correct the growth defect of topA null mutants efficiently. This synergistic effect can be explained by the fact that some R-loops must not be degraded in order for the RNA to be available for protein synthesis. Topoisomerase III can presumably repress the formation of such R-loops or cause their destabilization to prevent RNA degradation. This is supported by the fact that overproduction of this topoisomerase corrects the negative effect of overexpressing RNase H activity on the growth of topA null mutants at low temperatures. Moreover, the fact that DNA topoisomerase III does not relax global supercoiling supports our previous conclusion that R-loop formation, and therefore the essential function of DNA topoisomerase I, involves local, rather than global, supercoiling.


Assuntos
DNA Topoisomerases Tipo I/genética , Escherichia coli/genética , Genes Supressores , Mutação , Sequência de Bases , Primers do DNA , Escherichia coli/enzimologia , Escherichia coli/crescimento & desenvolvimento , Ligação Proteica , Ribonuclease H/metabolismo , Transcrição Gênica
13.
Arthritis Care Res ; 13(2): 100-11, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14635283

RESUMO

OBJECTIVES: The main objectives of this experimental case series were to evaluate the feasibility of a modified dance-based exercise program with low ground impacts in persons with rheumatoid arthritis (RA) functional class III and to describe its effects on locomotor ability. The relationship between 3 locomotor tests and their responsiveness also were addressed. METHODS: Ten female subjects participated in an 8-week exercise program. Locomotor ability was measured before and after the program using the 50-foot test of walking time, the 6-minute test of walking distance, and the locomotion biomechanical analysis. RESULTS: All subjects showed a high compliance (92.5% presence at sessions) over the 8 weeks of exercise without any aggravation in disease status. They were able to train efficiently at moderate intensity up to 25 minutes. Significant improvements were found in locomotor ability, with a higher responsiveness measured by the locomotion biomechanical analysis, followed by the 6-minute gait test and the 50-foot gait test. Inconsistent relationships between tests suggested that different locomotor abilities are required during tests. CONCLUSION: These results support the feasibility of a modified dance-based exercise program for persons with severe RA. With high levels of responsiveness, the detailed biomechanical analysis and the 6-minute gait test are recommended for the assessment of locomotor ability.


Assuntos
Artrite Reumatoide/reabilitação , Dança , Terapia por Exercício/métodos , Índice de Gravidade de Doença , Caminhada , Idoso , Artrite Reumatoide/classificação , Artrite Reumatoide/fisiopatologia , Artrite Reumatoide/psicologia , Fenômenos Biomecânicos , Teste de Esforço , Estudos de Viabilidade , Feminino , Marcha , Humanos , Perna (Membro)/fisiopatologia , Pessoa de Meia-Idade , Cooperação do Paciente/psicologia , Aptidão Física , Amplitude de Movimento Articular , Fatores de Tempo , Resultado do Tratamento
14.
J Biol Chem ; 275(15): 11257-63, 2000 Apr 14.
Artigo em Inglês | MEDLINE | ID: mdl-10753935

RESUMO

It has been suggested that the major function of DNA topoisomerase I in Escherichia coli is to suppress the formation of R-loops, which could inhibit growth. Although the currently available data suggest that the inhibitory effect of R-loops is exerted at the level of gene expression, this has never been demonstrated. In the present report, we show that rRNA synthesis is significantly impaired at the level of transcription elongation in a bacterial strain lacking DNA topoisomerase I. We found that this inhibition is due to transcriptional blocks. RNase H overproduction is also shown to considerably reduce the extent of such transcriptional blocks during rRNA synthesis. Moreover, one of these transcriptional blockage sites is located within a region where extensive R-loop formation was previously shown to occur on a plasmid DNA in the absence of DNA topoisomerase I. Together, these results allow us to propose that an important function of DNA topoisomerase I is to inhibit the formation of R-loops, which may otherwise translate into roadblocks for RNA polymerases. Our results also highlight the potential regulatory role of DNA supercoiling at the level of transcription elongation.


Assuntos
DNA Topoisomerases Tipo I/fisiologia , Escherichia coli/genética , RNA Ribossômico/biossíntese , Ribonuclease H/fisiologia , Transcrição Gênica , DNA Super-Helicoidal/fisiologia , RNA Ribossômico 16S/análise , RNA Ribossômico 23S/análise
15.
J Mol Biol ; 294(2): 321-32, 1999 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-10610761

RESUMO

We have recently presented evidence that inhibitory R-loops form during transcription in topA null mutants when the nascent RNA anneals with the template DNA strand behind the moving RNA polymerase. This was supported by the results of in vitro transcription assays and by in vivo studies in which R-loop formation was shown to be inhibited by coupled transcription-translation. The results presented here support this model and further demonstrate the link between R-loop formation and growth inhibition of topA null mutants. First, we show that RNase H activity is essential in the absence of DNA topoisomerase I. This was observed even if the growth of the topA null mutant is compensated for by naturally selected mutations, that also reduce global supercoiling below the wild-type level. Second, we show that R-loop-dependent hypernegative supercoiling increases as the temperature decreases and correlates with growth inhibition of topA null mutants. In fact, RNase H overproduction is shown to be detrimental to cell growth at 21 degrees C. Presumably, several mRNAs are being sequestered in R-loops and their degradation by RNase H significantly impedes protein synthesis. We propose that a reduced transcription velocity at low temperatures favors the annealing of the nascent RNA with the template strand behind the moving RNA polymerase, in agreement with the results of previous studies. Finally, based on the currently available data on R-loop formation, we present a model that explains the sensitivity of topA null mutants to various environmental changes that are often accompanied by transient inhibition of translation.


Assuntos
DNA Topoisomerases Tipo I/genética , DNA Bacteriano/química , Escherichia coli/genética , RNA Bacteriano/química , Divisão Celular/genética , DNA Topoisomerases Tipo I/metabolismo , DNA Bacteriano/genética , Escherichia coli/citologia , Mutação , Conformação de Ácido Nucleico , Ribonuclease H/genética , Ribonuclease H/metabolismo , Temperatura
16.
Int J Neurosci ; 99(1-4): 59-67, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10495196

RESUMO

The age difference observed between Wernicke's and Broca's aphasics has been understood by some authors as an indication of a progressive diminution of the contribution of the right hemisphere to language throughout the life span. To test this hypothesis, 24 right-hemisphere-damaged (RHD) and 24 normal control adults were submitted to six tasks looking at different aspects of language abilities. Results showed that RHDs performed less well than normal subjects on 3 of these tasks, but that this difference was not linked with age (younger than 55 versus older than 65 years). Consequently, these results do not support models of functional brain organization suggesting a decreasing contribution of the right hemisphere to language abilities with age.


Assuntos
Envelhecimento/fisiologia , Afasia de Broca/fisiopatologia , Afasia de Wernicke/fisiopatologia , Lateralidade Funcional/fisiologia , Idioma , Estimulação Acústica , Adulto , Idoso , Análise de Variância , Comunicação , Lobo Frontal/fisiologia , Humanos , Pessoa de Meia-Idade , Estimulação Luminosa , Lobo Temporal/fisiologia , Aprendizagem Verbal/fisiologia
17.
Arch Phys Med Rehabil ; 80(7): 791-800, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10414764

RESUMO

OBJECTIVE: To objectively quantify muscle strength changes over the course of functional rehabilitation and up to 15 months postdischarge in individuals with spinal cord injury (SCI). METHOD: Hand-held dynamometry was used to evaluate the strength of six muscle groups in 31 individuals after acute SCI (tetraplegia, n = 13, paraplegia, n = 18). Assessment was performed by a single research therapist at admittance and discharge from functional rehabilitation and 3 months and 15 months after discharge. RESULTS: There were significant increases of mean strength values for all muscle groups between admittance and discharge in individuals with parapalegia (median value between 13% and 22%) and tetraplegia (median value between 33% and 83%). Three months after discharge, only individuals with tetraplegia continued to significantly improve their mean strength for four muscle groups (elbow flexors-extensors and shoulder flexors-extensors). One year later, elbow flexors were significantly improved in both paraplegic and tetraplegic persons, while shoulder extensors showed significant gains only in individuals with paraplegia. Study results showed a large variability in the individual profiles of upper limb strength recovery, particularly in tetraplegic individuals. Although some individuals showed strength gains exceeding 200%, some strength decreases were noted. CONCLUSION: Recovery of muscle strength in individuals with tetraplegia over individuals with parapalegia continues for a longer period since it depends initially on recovery of muscle innervation. This study quantified strength improvements during rehabilitation and clearly showed that these gains can be maintained or even increased when the person returns to community living.


Assuntos
Atividades Cotidianas , Hemiplegia/complicações , Debilidade Muscular/diagnóstico , Debilidade Muscular/reabilitação , Quadriplegia/complicações , Traumatismos da Medula Espinal/complicações , Adolescente , Adulto , Articulação do Cotovelo/fisiopatologia , Feminino , Seguimentos , Humanos , Contração Isométrica , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Debilidade Muscular/etiologia , Debilidade Muscular/fisiopatologia , Articulação do Ombro/fisiopatologia , Traumatismos da Medula Espinal/classificação , Fatores de Tempo , Resultado do Tratamento
18.
Can J Public Health ; 90(3): 156-9, 1999.
Artigo em Francês | MEDLINE | ID: mdl-10401163

RESUMO

OBJECTIVES: To determine the prevalence of tuberculosis infection related to a case of pulmonary and laryngeal tuberculosis in a workplace and to study PPD predictors. METHODS: The Mantoux skin test (PPD) was offered to all potentially infected contacts. Participants were asked to answer a questionnaire. RESULTS: Among 112 exposed employees, 92 (82.1%) were tested. At the 5 mm level, 65.2% of employees had positive tuberculin skin test (PPD). By controlling prior BCG and the degree of exposure, it showed a positive association between age and PPD (RC: 3.5; 95% CI: 1.25-10.03). When age and BCG were controlled, high exposure was statistically associated with PPD results (RC: 5.6; 95% CI: 1.25-24.68). CONCLUSION: The observed prevalence rate is probably related to the fact that the index case was very infectious and had contact in an enclosed area over a long period of time before withdrawal from work.


Assuntos
Doenças Profissionais/epidemiologia , Tuberculose Laríngea/epidemiologia , Tuberculose Laríngea/transmissão , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/transmissão , Adulto , Distribuição por Idade , Estudos Epidemiológicos , Humanos , Indústrias , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/diagnóstico , Prevalência , Quebeque/epidemiologia , Inquéritos e Questionários , Teste Tuberculínico , Tuberculose Laríngea/diagnóstico , Tuberculose Pulmonar/diagnóstico
19.
Nucleic Acids Res ; 27(13): 2745-52, 1999 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-10373592

RESUMO

In order to clone the gene encoding a type I DNA topoisomerase from Leishmania donovani, a PCR-amplified DNA fragment obtained with degenerate oligodeoxyribonucleotides was used to screen a genomic library from this parasite. An open reading frame of 1905 bases encoding a putative protein of 635 amino acid residues was isolated. A substantial part of the protein shares a significant degree of homology with the sequence of other known members of the IB topoisomerase family, in a highly conserved region of these enzymes termed the core domain. However, homology is completely lost after this conserved central core. Moreover, no conventional active tyrosine site could be identified. In fact, the protein expressed in Escherichia coli did not show any relaxation activity in vitro and was unable to complement a mutant deficient in topoisomerase I activity. The results of Southern blot experiments strongly suggested that the cloned gene was not a pseudogene. Northern analysis revealed that the gene was transcribed in its full length and also excluded the possibility that some form of splicing is necessary to produce a mature messenger. Furthermore, our results indicate that the gene is preferentially expressed in actively growing L.donovani promastigotes and that it is also expressed in other kinetoplastid parasites.


Assuntos
DNA Topoisomerases Tipo I/genética , Genes de Protozoários , Proteínas de Protozoários/genética , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA Topoisomerases Tipo I/metabolismo , Escherichia coli , Leishmania donovani , Dados de Sequência Molecular , Proteínas de Protozoários/metabolismo , Alinhamento de Sequência , Análise de Sequência
20.
J Biol Chem ; 274(23): 16654-8, 1999 Jun 04.
Artigo em Inglês | MEDLINE | ID: mdl-10347233

RESUMO

It has been suggested that the essential function of DNA topoisomerase I in Escherichia coli is to prevent chromosomal DNA from reaching an unacceptably high level of global negative supercoiling. However, other in vivo studies have shown that DNA topoisomerase I is very effective in removing local negative supercoiling generated during transcription elongation. To determine whether topoisomerase I is essential for controlling global or local DNA supercoiling, we have prepared a set of topA null mutant strains in combination with different plasmid DNAs. Although we found a correlation between the severity of the growth defect with both transcription-induced and global supercoiling, near to complete growth inhibition correlated only with transcription-induced supercoiling. This result strongly suggests that the major function of DNA topoisomerase I is to relax local negative supercoiling generated during transcription elongation.


Assuntos
DNA Topoisomerases Tipo I/metabolismo , Escherichia coli/enzimologia , Conformação de Ácido Nucleico , Transcrição Gênica , Antiporters/genética , Antiporters/metabolismo , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , DNA Bacteriano/química , DNA Bacteriano/metabolismo , Escherichia coli/genética , Escherichia coli/crescimento & desenvolvimento , Regiões Promotoras Genéticas , Resistência a Tetraciclina/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA